Patient-reported respiratory symptoms in cystic fibrosis

Journal of Cystic Fibrosis

Volumn 8, Issue 4, 2009, Pages 245-252

  Goss, C H ^a   Edwards, T C ^a   Ramsey, B W ^b,c   Aitken, M L ^a   Patrick, D L ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b SEATTLE CHILDREN S RESEARCH INSTITUTE   (United States)

^c UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

Cystic fibrosis; Patient reported outcomes; Qualitative study; Respiratory symptoms

Indexed keywords

ABSENTEEISM; ADOLESCENT; ADULT; ANXIETY; ARTICLE; BREATHING DISORDER; CHEST TIGHTNESS; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; COUGHING; CYSTIC FIBROSIS; DAILY LIFE ACTIVITY; DEPRESSION; DYSPNEA; EMOTIONALITY; FEMALE; FEVER; FRUSTRATION; HEALTH SURVEY; HUMAN; IRRITABILITY; LONELINESS; LUNG DISEASE; MALE; OUTCOME ASSESSMENT; PRESCHOOL CHILD; QUALITATIVE RESEARCH; RESPIRATORY TRACT DISEASE; SCHOOL CHILD; SELF REPORT; SLEEP DISORDER; SOCIAL PSYCHOLOGY; SPUTUM; WHEEZING;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; COUGH; CYSTIC FIBROSIS; DYSPNEA; FEMALE; HUMANS; INTERVIEWS AS TOPIC; MALE; MEDICAL RECORDS; QUALITATIVE RESEARCH; RESPIRATION DISORDERS; RESPIRATORY SOUNDS; SEVERITY OF ILLNESS INDEX;

EID: 67649467310     PISSN: 15691993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcf.2009.04.003     Document Type: Article

References (56)

1. Ramsey B.W., and Boat T.F. Outcome measures for clinical trials in cystic fibrosis. Summary of a Cystic Fibrosis Foundation consensus conference. J Pediatr 124 2 (Feb 1994) 177-192
2. Marshall B.C. Pulmonary exacerbations in cystic fibrosis: it's time to be explicit!. Am J Respir Crit Care Med 169 7 (Apr 1 2004) 781-782
3. Cystic Fibrosis Foundation, Patient Registry 2006 Annual Data Report (Sep 2007) Bethesda, Maryland
4. Hiatt P.W., Grace S.C., Kozinetz C.A., Raboudi S.H., Treece D.G., Taber L.H., et al. Effects of viral lower respiratory tract infection on lung function in infants with cystic fibrosis. Pediatrics 103 3 (Mar 1999) 619-626
5. Regelmann W.E., Elliott G.R., Warwick W.J., and Clawson C.C. Reduction of sputum Pseudomonas aeruginosa density by antibiotics improves lung function in cystic fibrosis more than do bronchodilators and chest physiotherapy alone. Am Rev Respir Dis 141 4 Pt 1 (Apr 1990) 914-921
6. Smith A.L., Redding G., Doershuk C., Goldmann D., Gore E., Hilman B., et al. Sputum changes associated with therapy for endobronchial exacerbation in cystic fibrosis. J Pediatr 112 4 (Apr 1988) 547-554
7. Wat D., and Doull I. Respiratory virus infections in cystic fibrosis. Paediatr Respir Rev 4 3 (Sep 2003) 172-177
8. van Ewijk B.E., van der Zalm M.M., Wolfs T.F., and van der Ent C.K. Viral respiratory infections in cystic fibrosis. J Cyst Fibros 4 Suppl 2 (Aug 2005) 31-36
9. Ramsey B.W., Pepe M.S., Quan J.M., Otto K.L., Montgomery A.B., Williams-Warren J., et al. Intermittent administration of inhaled tobramycin in patients with cystic fibrosis. Cystic Fibrosis Inhaled Tobramycin Study Group. N Engl J Med 340 1 (Jan 7 1999) 23-30
10. Wolter J.M., Bowler S.D., Nolan P.J., and McCormack J.G. Home intravenous therapy in cystic fibrosis: a prospective randomized trial examining clinical, quality of life and cost aspects. Eur Respir J 10 4 (Apr 1997) 896-900
11. Munzenberger P.J., Van Wagnen C.A., Abdulhamid I., and Walker P.C. Quality of life as a treatment outcome in patients with cystic fibrosis. Pharmacotherapy 19 4 (Apr 1999) 393-398
12. Fuchs H.J., Borowitz D.S., Christiansen D.H., Morris E.M., Nash M.L., Ramsey B.W., et al. Effect of aerosolized recombinant human DNase on exacerbations of respiratory symptoms and on pulmonary function in patients with cystic fibrosis. The Pulmozyme Study Group. N Engl J Med 331 10 (Sep 8 1994) 637-642
13. Ramsey B.W., Pepe M.S., Quan J.M., Otto K.L., Montgomery A.B., Williams-Warren J., et al. Intermittent administration of inhaled tobramycin in patients with cystic fibrosis. Cystic Fibrosis Inhaled Tobramycin Study Group. N Engl J Med 340 1 (Jan 7 1999) 23-30
14. Smith A.L., Doershuk C., Goldmann D., Gore E., Hilman B., Marks M., et al. Comparison of a beta-lactam alone versus beta-lactam and an aminoglycoside for pulmonary exacerbation in cystic fibrosis. J Pediatr 134 4 (Apr 1999) 413-421
15. Jones P.W., Quirk F.H., Baveystock C.M., and Littlejohns P. A self-complete measure of health status for chronic airflow limitation. The St. George's Respiratory Questionnaire. Am Rev Respir Dis 145 6 (Jun 1992) 1321-1327
16. Quittner A.L., Buu A., Messer M.A., Modi A.C., and Watrous M. Development and validation of The Cystic Fibrosis Questionnaire in the United States: a health-related quality-of-life measure for cystic fibrosis. Chest 128 4 (Oct 2005) 2347-2354
17. Stone A.A., Broderick J.E., Shiffman S.S., and Schwartz J.E. Understanding recall of weekly pain from a momentary assessment perspective: absolute agreement, between- and within-person consistency, and judged change in weekly pain. Pain 107 1-2 (Jan 2004) 61-69
18. Stone A.A., Schwartz J.E., Broderick J.E., and Shiffman S.S. Variability of momentary pain predicts recall of weekly pain: a consequence of the peak (or salience) memory heuristic. Pers Soc Psychol Bull 31 10 (Oct 2005) 1340-1346
19. Broderick J.E., Stone A.A., Calvanese P., Schwartz J.E., and Turk D.C. Recalled pain ratings: a complex and poorly defined task. J Pain 7 2 (Feb 2006) 142-149
20. Kahneman D., Krueger A.B., Schkade D.A., Schwarz N., and Stone A.A. A survey method for characterizing daily life experience: the day reconstruction method. Science 306 5702 (Dec 3 2004) 1776-1780
21. Bronfenbrenner U. The Ecology of Human Development: Experiments by Nature and Design (1979), Harvard University Press, Cambridge, MA
22. Fowler F. Survey research methods. 2nd ed. ed. Newbury Park: Sage; 1993.
23. Jabine P., Stras M.L., Tanor J.M., and Tourangeau R. Cognitive aspects of survey methodology: Building a bridge between disciplines (1984), National Academy Press, Washington, DC
24. Willis E., Miller R., and Wyn J. Gendered embodiment and survival for young people with cystic fibrosis. Soc Sci Med 53 9 (Nov 2001) 1163-1174
25. Williams B., Mukhopadhyay S., Dowell J., and Coyle J. Problems and solutions: accounts by parents and children of adhering to chest physiotherapy for cystic fibrosis. Disabil Rehabil 29 14 (Jul 30 2007) 1097-1105
26. Palmer M.L., and Boisen L.S. Cystic fibrosis and the transition to adulthood. Soc Work Health Care 36 1 (2002) 45-58
27. Brumfield K., and Lansbury G. Experiences of adolescents with cystic fibrosis during their transition from paediatric to adult health care: a qualitative study of young Australian adults. Disabil Rehabil 26 4 (Feb 18 2004) 223-234
28. Lowton K., and Ballard K.D. Adult cystic fibrosis patients' experiences of primary care consultations: a qualitative study. Br J Gen Pract 56 528 (Jul 2006) 518-525
29. Saxe-Braithwaite M.E., and Chapman J.S. Life on hold: the experience of the support person involved in a lung transplant program. Can J Nurs Res 24 3 (1992) 69-80
30. Lowton K. 'Double or quits': perceptions and management of organ transplantation by adults with cystic fibrosis. Soc Sci Med 56 6 (Mar 2003) 1355-1367
31. Chapman E., Landy A., Lyon A., Haworth C., and Bilton D. End of life care for adult cystic fibrosis patients: facilitating a good enough death. J Cyst Fibros 4 4 (Dec 2005) 249-257
32. Rosenfeld M., Emerson J., Williams-Warren J., Pepe M., Smith A., Montgomery A.B., et al. Defining a pulmonary exacerbation in cystic fibrosis. J Pediatr 139 3 (Sep 2001) 359-365
33. Henry B., Aussage P., Grosskopf C., and Goehrs J.M. Development of the Cystic Fibrosis Questionnaire (CFQ) for assessing quality of life in pediatric and adult patients. Qual Life Res 12 1 (Feb 2003) 63-76
34. Quittner A.L., Sweeny S., Watrous M., Munzenberger P., Bearss K., Gibson N.A., et al. Translation and linguistic validation of a disease-specific quality of life measure for cystic fibrosis. J Pediatr Psychol 25 6 (Sep 2000) 403-414
35. Modi A.C., and Quittner A.L. Validation of a disease-specific measure of health-related quality of life for children with cystic fibrosis. J Pediatr Psychol 28 8 (Dec 2003) 535-545
36. Jones P.W., and Bosh T.K. Quality of life changes in COPD patients treated with salmeterol. Am J Respir Crit Care Med 155 4 (Apr 1997) 1283-1289
37. Wilson C.B., Jones P.W., O'Leary C.J., Cole P.J., and Wilson R. Validation of the St. George's Respiratory Questionnaire in bronchiectasis. Am J Respir Crit Care Med 156 2 Pt 1 (Aug 1997) 536-541
38. Lahdensuo A., Haahtela T., Herrala J., Kava T., Kiviranta K., Kuusisto P., et al. Randomised comparison of guided self management and traditional treatment of asthma over one year. BMJ 312 7033 (Mar 23 1996) 748-752
39. Gee L., Abbott J., Conway S.P., Etherington C., and Webb A.K. Development of a disease specific health related quality of life measure for adults and adolescents with cystic fibrosis. Thorax 55 11 (Nov 2000) 946-954
40. Sawicki G.S., Sellers D.E., and Robinson W.M. Self-Reported Physical and Psychological Symptom Burden in Adults with Cystic Fibrosis. J Pain Symptom Manage (Jan 19 2008)
41. Piedra P.A., Cron S.G., Jewell A., Hamblett N., McBride R., Palacio M.A., et al. Immunogenicity of a new purified fusion protein vaccine to respiratory syncytial virus: a multi-center trial in children with cystic fibrosis. Vaccine 21 19-20 (Jun 2 2003) 2448-2460
42. Wijkstra P.J., TenVergert E.M., Van Altena R., Otten V., Postma D.S., Kraan J., et al. Reliability and validity of the chronic respiratory questionnaire (CRQ). Thorax 49 5 (May 1994) 465-467
43. Klijn P.H., van Stel H.F., Quittner A.L., van der N.J., Doeleman W., van der Schans C.P., et al. Validation of the Dutch cystic fibrosis questionnaire (CFQ) in adolescents and adults. J Cyst Fibros 3 1 (Mar 2004) 29-36
44. Quittner A.L., Sweeny S., Watrous M., Munzenberger P., Bearss K., Gibson N.A., et al. Translation and linguistic validation of a disease-specific quality of life measure for cystic fibrosis. J Pediatr Psychol 25 6 (Sep 2000) 403-414
45. Retsch-Bogart G.Z., Burns J.L., Otto K.L., Liou T.G., McCoy K., Oermann C., et al. A phase 2 study of aztreonam lysine for inhalation to treat patients with cystic fibrosis and Pseudomonas aeruginosa infection. Pediatr Pulmonol 43 1 (Jan 2008) 47-58
46. Fletcher C.M., Elmes P.C., Fairbairn A.S., and Wood C.H. The significance of respiratory symptoms and the diagnosis of chronic bronchitis in a working population. Br Med J 5147 (Aug 29 1959) 257-266
47. de Jong W., van der Schans C.P., Mannes G.P., van Aalderen W.M., Grevink R.G., and Koeter G.H. Relationship between dyspnoea, pulmonary function and exercise capacity in patients with cystic fibrosis. Respir Med 91 1 (Jan 1997) 41-46
48. Aitken R.C. Measurement of feelings using visual analogue scales. Proc R Soc Med 62 10 (Oct 1969) 989-993
49. Orenstein D.M., Holt L.S., Rebovich P., Campbell T., and Nixon P. Measuring ease of breathing in young patients with cystic fibrosis. Pediatr Pulmonol 34 6 (Dec 2002) 473-477
50. Prasad S.A., Randall S.D., and Balfour-Lynn I.M. Fifteen-count breathlessness score: an objective measure for children. Pediatr Pulmonol 30 1 (Jul 2000) 56-62
51. Eakin E.G., Resnikoff P.M., Prewitt L.M., Ries A.L., and Kaplan R.M. Validation of a new dyspnea measure: the UCSD Shortness of Breath Questionnaire. University of California, San Diego. Chest 113 3 (Mar 1998) 619-624
52. Leidy N.K., Schmier J.K., Jones M.K., Lloyd J., and Rocchiccioli K. Evaluating symptoms in chronic obstructive pulmonary disease: validation of the Breathlessness, Cough and Sputum Scale. Respir Med 97 (Jan 2003) S59-S70 Suppl A
53. Leidy N.K., Rennard S.I., Schmier J., Jones M.K., and Goldman M. The breathlessness, cough, and sputum scale: the development of empirically based guidelines for interpretation. Chest 124 6 (Dec 2003) 2182-2191
54. Van Der M.T., Willemse B.W., Schokker S., Ten Hacken N.H., Postma D.S., and Juniper E.F. Development, validity and responsiveness of the Clinical COPD Questionnaire. Health Qual Life Outcomes 1 1 (Apr 28 2003) 13
55. Au D.H., Blough D.K., Kirchdoerfer L., Weiss K.B., Udris E.M., and Sullivan S.D. Development of a quantifiable symptom assessment tool for patients with chronic bronchitis: the Chronic Bronchitis Symptoms Assessment Scale. COPD 2 2 (Jun 2005) 209-216
56. Goss C.H., Edwards T., Lymp J.F., Cooper P., Ramsey B.W., Aitken M.L., et al. Patient-reported respiratory symptoms in cystic fibrosis: initial validation. Pediatr Pulmonol S30 (2007) 409